Arvinas, Inc. (ARVN) Downgraded to Equal-Weight by Wells Fargo

Market Context

Arvinas, Inc. operates in the Healthcare sector. The stock currently trades at $8.35 with a market capitalization of $974.3M. The stock has gained 21.3% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Wells Fargo's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Arvinas, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 05, 2026	Wedbush	Neutral	N/A
Aug 05, 2026	Wells Fargo	Equal-Weight	N/A
Aug 04, 2026	BTIG	Buy	N/A
Jun 03, 2026	Stephens & Co.	Overweight	N/A
May 13, 2026	Barclays	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View ARVN Stock Page